Figure 5
From: Impact of preoperative anemia on relapse and survival in breast cancer patients
LRFS, LNMFS, DMFS, RFS, and OS for patients in stage III with and without anemia. A. LRFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage III. B. LNMFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage III. C. DMFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage III. D. RFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage III. E. OS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage III.